Lack of effects of fibrinogen degradation products on specific binding of [3H]spiroperidol and [3H]ADTN

Pol J Pharmacol Pharm. 1983;35(1):45-7.

Abstract

No effect of fibrinogen degradation products on specific binding of [3H]spiroperidol and [3H]ADTN was observed. Low molecular weight peptides derived from fibrinogen degradation by plasmin (FDP) increase the motor activity of rats [7] augment apomorphine- and amphetamine-induced stereotypy and diminish haloperidol catalepsy [2]. It has been suggested that FDP interact with central dopamine receptor [2]. Taking the above considerations into account it was decided to investigate the effect of FDP on specific binding of [3H] spiroperidol and 2-amino-6,7-dihydroxy-1,2,3,4-tetrahydronaphthalene ([3H]ADTN).

MeSH terms

  • Animals
  • Apomorphine / pharmacology
  • Butyrophenones / metabolism*
  • Dopamine / pharmacology
  • Fibrin Fibrinogen Degradation Products / physiology*
  • In Vitro Techniques
  • Male
  • Molecular Weight
  • Naphthalenes / metabolism*
  • Rats
  • Receptors, Dopamine / physiology
  • Spiperone / metabolism*
  • Tetrahydronaphthalenes / metabolism*

Substances

  • Butyrophenones
  • Fibrin Fibrinogen Degradation Products
  • Naphthalenes
  • Receptors, Dopamine
  • Tetrahydronaphthalenes
  • Spiperone
  • ADTN
  • Apomorphine
  • Dopamine